Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer

NEXT STORY
Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder
PREV STORY
BetterLife Pharma Announces Dr. Eleanor Fish to Retain Role as Key Scientific Advisor Following Invitation to Join Government COVID-19 Task Force
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting

PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual ...

author_avatar
NASDAQ Market News

Trinitas-St. Joseph’s Behavioral Health Network Offers Innovative Alternative Treatment for Depression

author_avatar
NASDAQ Market News

OncoResponse Raises $40.6 Million Series C Financing

author_avatar
NASDAQ Market News